한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

황해쑥추출분말

황해쑥추출분말

MFDS recognition no.2024-21
Approval routeNotified (고시형) — listed in MFDS public standards
Daily intake (as approved)240.0–240.0 mg/일
Approval holder동아제약(주)

Approved wording (Korean original)

위점막을 보호하여 위건강에 도움을 줄 수 있음

Precautions (Korean original)

○ 영·유아, 어린이, 임산부 및 수유부는 섭취를 피할 것 ○ 특정질환(알레르기 체질 등)이 있는 분은 섭취에 주의 ○ 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것 ○ 위염치료제 등 의약품을 복용하시는 분은 섭취 전 전문가와 상담할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.